Market Tracker

01/20 5:16pm ET

OPKO Health Inc (NASDAQ:OPK)

8.64
Delayed Data
As of Jan 20
 -0.11 / -1.26%
Today’s Change
7.12
Today|||52-Week Range
12.15
-7.10%
Year-to-Date
Better Buy: Opko Health, Inc. vs. Qiagen
Jan 18 / MotleyFool.com - Paid Partner Content
How a Bust Caused Opko Health Shares to Tumble in 2016
Jan 10 / MotleyFool.com - Paid Partner Content
It's Full Speed Ahead for Opko Health After Pipeline Stumble
Jan 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close8.75
Today’s open8.76
Day’s range8.62 - 8.81
Volume2,914,551
Average volume (3 months)4,312,354
Market cap$4.8B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-26.67%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratioNM
Price/Sales9.97
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-2.04-4.24%
VRXValeant Pharmaceutic...-0.17-1.14%
GRFSGrifols SA+0.04+0.24%
TAROTaro Pharmaceutical ...-1.34-1.32%
Data as of 4:02pm ET, 01/20/2017

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
CFO, Treasurer, &
Chief Accounting Officer
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts